Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for Chronic Depression
NCT00360724Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Aug 2006
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of duloxetine in persistent depressive disorder (PDD), depressive disorder not otherwise specified (DD-NOS), sponsored by New York State Psychiatric Institute. Started Aug 2006; status: completed.
02
Drugs
duloxetine
03
Conditions
persistent depressive disorder (PDD)depressive disorder not otherwise specified (DD-NOS)
Beyond the preview
Go deeper on NCT00360724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00360724.